Date Time
Scientists make DNA breakthrough which could identify why some people are more affected by Covid-19
Scientists from the MRC Weatherall Institute of Molecular Medicine at Oxford University have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.
This breakthrough will improve understanding of how differences in DNA sequences can lead to increased risks of developing many different diseases.
The method, which is around 1000 times more accurate than existing techniques, enables scientists to measure the contacts between different pieces of DNA, which are a million base pairs apart to the nearest base pair. This is the equivalent of being able to measure contacts in the DNA fibre that are 1km apart to the nearest millimetre.
The Oxford Africa Conference Innovation Fair took place on the 28th and 29th of May 2021 with a cohort of 11 highly innovative companies, based across five African countries. Participants were selected from over 150 applications. The companies went through a two-day program which kicked off with a ‘fireside chat’ with Maya Horgan Famodu, founder […]
Magdalen College Oxford is seeking a strategic partner to accelerate the development of The Oxford Science Park , one of the UK’s leading parks for science and technology companies, and has. | May 25, 2021
(0)
Magdalen College Oxford is seeking a strategic partner to accelerate the development of The Oxford Science Park (TOSP), one of the UK s leading parks for science and technology companies, and has appointed real estate services firm Cushman Wakefield (NYSE: CWK) to lead the process. With the global life science sector well-capitalized and making significant innovation advances, there is an increasing demand for high quality laboratory and office space.
The science park, 100% owned and managed by Magdalen College, is home to more than 100 leading companies active across a range of therapeutic areas and technologies including infectious diseases, cancer and artificial intelligence. Many tenants have been involved in the fight against COVID-19 through vaccines, sequencing, viral vectors and test reagents.
The Company will invest in a combination of large, medium and smaller companies listed in the UK. We are not constrained by the weightings of any index; we focus instead on controlling absolute risk by diversifying on the basis of underlying company characteristics such as size, industry, economic sensitivity, clients and management. In normal circumstances up to half the portfolio will be invested in FTSE 100 companies; the remainder will be divided between small- and medium-sized companies. On occasions the Manager will buy shares listed overseas. The Manager may also invest a maximum of 15% in other listed trusts. It is a pleasure to report that, after a period of disappointing performance, the portfolio bounced back in the first half of the year, with NAV increasing by 33.0% against the benchmark s 18.5%. The previous financial year had started hopefully, only for those hopes to be dashed in March 2020 by the effects of the pandemi